WLM PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
WLM PHARMA
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€27,289
2024 · €14,522+€12,767
Equity
€58,427
2024 · €32,804+€25,623
Cash
€200,783
2024 · €194,007+€6,776
Balance sheet total
€1.4m
2024 · €1.5m-€147,577
Largest movements
Assets
- Intangible fixed assets -€87,500
down €87,500 (-11.1%), from €787,500 to €700,000
- Tangible fixed assets -€44,764
down €44,764 (-26.4%), from €169,460 to €124,697
of which Plant, machinery and equipment: -€29,360
Equity and liabilities
- Debts after one year -€145,892
down €145,892 (-29.3%), from €497,639 to €351,747
- Reserves +€25,623
up €25,623 (+200.1%), from €12,804 to €38,427
- Other debts -€16,476
down €16,476 (-2.4%), from €690,263 to €673,787
Income statement
- Staff costs -€25,280
down €25,280 (-17.0%), from €148,275 to €122,995
- Taxes +€9,908
up €9,908 (+165.8%), from €5,977 to €15,885
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€14,522
Gross operating margin
+€2,574
Staff costs
+€25,280
Depreciation
-€3,007
Other operating charges
+€345
Financial income
-€1,332
Financial charges
-€1,185
Taxes
-€9,908
Result 2025
€27,289
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€154,334
Investment
€0
Financing
-€147,558
Cash 2024
€194,007
From operations (derived)
+€154,334
Net result for the year
+€27,289
Depreciation
+€132,264
Stocks and contracts
+€5,023
Receivables within one year
+€15,299
Deferred charges and accrued income
+€1,768
Trade debts
-€9,826
Tax, wage and social debts
-€1,726
Other debts
-€16,476
Accrued charges and deferred income
+€719
Financing
-€147,558
Debts after one year
-€145,892
Contributions, distributions and other
-€1,666
Cash 2025
€200,783
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,532,279 | €1,384,702 | -€147,577 | -9.6% |
| Fixed assets | 21/28 | €956,960 | €824,697 | -€132,264 | -13.8% |
| Intangible fixed assets | 21 | €787,500 | €700,000 | -€87,500 | -11.1% |
| Tangible fixed assets | 22/27 | €169,460 | €124,697 | -€44,764 | -26.4% |
| Land and buildings | 22 | €5,210 | €4,669 | -€541 | -10.4% |
| Plant, machinery and equipment | 23 | €117,439 | €88,079 | -€29,360 | -25.0% |
| Furniture and vehicles | 24 | €17,648 | €10,076 | -€7,572 | -42.9% |
| Other tangible fixed assets | 26 | €29,163 | €21,873 | -€7,291 | -25.0% |
| Current assets | 29/58 | €575,319 | €560,005 | -€15,314 | -2.7% |
| Stocks and contracts in progress | 3 | €212,186 | €207,163 | -€5,023 | -2.4% |
| Stocks | 30/36 | €212,186 | €207,163 | -€5,023 | -2.4% |
| Amounts receivable within one year | 40/41 | €160,976 | €145,677 | -€15,299 | -9.5% |
| Trade receivables | 40 | €160,473 | €145,367 | -€15,105 | -9.4% |
| Other amounts receivable | 41 | €504 | €310 | -€194 | -38.5% |
| Cash at bank and in hand | 54/58 | €194,007 | €200,783 | +€6,776 | +3.5% |
| Deferred charges and accrued income | 490/1 | €8,150 | €6,382 | -€1,768 | -21.7% |
| Total equity and liabilities | 10/49 | €1,532,279 | €1,384,702 | -€147,577 | -9.6% |
| Equity | 10/15 | €32,804 | €58,427 | +€25,623 | +78.1% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €12,804 | €38,427 | +€25,623 | +200.1% |
| Distributable reserves | 133 | €12,804 | €38,427 | +€25,623 | +200.1% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €1,499,476 | €1,326,275 | -€173,200 | -11.6% |
| Amounts payable after more than one year | 17 | €497,639 | €351,747 | -€145,892 | -29.3% |
| Financial debts | 170/4 | €497,639 | €351,747 | -€145,892 | -29.3% |
| Amounts payable within one year | 42/48 | €1,000,232 | €972,206 | -€28,027 | -2.8% |
| Current portion of amounts payable after more than one year | 42 | €145,892 | €145,892 | = | 0.0% |
| Trade debts | 44 | €128,012 | €118,186 | -€9,826 | -7.7% |
| Suppliers | 440/4 | €128,012 | €118,186 | -€9,826 | -7.7% |
| Taxes, remuneration and social security | 45 | €36,066 | €34,340 | -€1,726 | -4.8% |
| Taxes | 450/3 | €20,219 | €19,053 | -€1,166 | -5.8% |
| Remuneration and social security | 454/9 | €15,847 | €15,287 | -€560 | -3.5% |
| Other amounts payable | 47/48 | €690,263 | €673,787 | -€16,476 | -2.4% |
| Accrued charges and deferred income | 492/3 | €1,604 | €2,323 | +€719 | +44.8% |
| Remuneration, social security and pensions | 62 | €148,275 | €122,995 | -€25,280 | -17.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €129,257 | €132,264 | +€3,007 | +2.3% |
| Other operating charges | 640/8 | €1,403 | €1,058 | -€345 | -24.6% |
| Gross operating margin | 9900 | €310,905 | €313,479 | +€2,574 | +0.8% |
| Operating profit (loss) | 9901 | €31,971 | €57,163 | +€25,192 | +78.8% |
| Financial income | 75/76B | €2,111 | €779 | -€1,332 | -63.1% |
| Recurring financial income | 75 | €2,111 | €779 | -€1,332 | -63.1% |
| Financial charges | 65/66B | €13,583 | €14,768 | +€1,185 | +8.7% |
| Recurring financial charges | 65 | €13,583 | €14,768 | +€1,185 | +8.7% |
| Profit (loss) for the period before taxes | 9903 | €20,499 | €43,174 | +€22,675 | +110.6% |
| Income taxes | 67/77 | €5,977 | €15,885 | +€9,908 | +165.8% |
| Profit (loss) for the period | 9904 | €14,522 | €27,289 | +€12,767 | +87.9% |
| Profit (loss) for the period to be appropriated | 9905 | €14,522 | €27,289 | +€12,767 | +87.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.